# Alphatec Holdings, Inc. (ATEC) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/ATEC
## Company Profile
- Ticker: ATEC
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: MedTech
## Stock Data
- Close: 10.72 USD
- Market cap: 1150344001.4 USD
- Last updated: 2026-10-05
## Business Overview
### Spine-Focused Medical Technology Company
Alphatec Holdings, operating as ATEC, develops technologies intended to improve the planning and execution of spine surgery. Its product ecosystem combines implants, biologics, imaging, surgical navigation, neuromonitoring, and procedural techniques.
### Procedural Innovation
ATEC develops procedure-specific systems for lateral, posterior, deformity, and other spine approaches. Techniques such as prone transpsoas surgery are supported by integrated instruments, implants, imaging, and intraoperative information intended to make complex procedures more reproducible.
### InformatiX Platform
The InformatiX platform brings together EOS imaging, surgical planning, navigation, robotics, and data analytics. It is designed to support decisions before and during surgery and to connect the company's hardware with imaging and clinical information.
### SafeOp Neuromonitoring
SafeOp provides automated nerve monitoring and surgical information during spine procedures. Integration with ATEC's procedural systems is intended to help surgeons understand patient anatomy and neural risk while operating.
### Implant and Biologics Portfolio
ATEC sells spinal implants, fixation systems, interbody devices, and biologic products used in fusion procedures. The company develops these products as part of complete procedural solutions rather than as stand-alone implants, creating cross-selling opportunities within surgeon accounts.
## Why The Stock Is Moving

As of Oct 5, 2026, ATEC closed up 6.88% at $10.72. No new same-company headline was identified in the current news window.

## Recent News
- 2021-07-28 13:05 EST — [ATEC to Participate in Upcoming Investor Conferences](https://biopharmsignal.com/news/ATEC/atec-to-participate-in-upcoming-investor-conferences-19b97e71) — Source: Alphatec Holdings, Inc.
- 2021-07-26 20:05 EST — [ATEC Appoints Beth Altman to Board of Directors](https://biopharmsignal.com/news/ATEC/atec-appoints-beth-altman-to-board-of-directors-75ec2721) — Source: Alphatec Holdings, Inc.
- 2021-07-12 13:00 EST — [ATEC Announces Select Preliminary Second Quarter 2021 Financial Results](https://biopharmsignal.com/news/ATEC/atec-announces-select-preliminary-second-quarter-2021-financial-results-b51ad69c) — Source: Alphatec Holdings, Inc.
- 2021-06-21 20:30 EST — [ATEC Appoints Marie Meynadier, Ph.D., to Board of Directors](https://biopharmsignal.com/news/ATEC/atec-appoints-marie-meynadier-ph-d-to-board-of-directors-65e95bda) — Source: Alphatec Holdings, Inc.
- 2021-06-07 13:00 EST — [ATEC Welcomes EOS Imaging Team](https://biopharmsignal.com/news/ATEC/atec-welcomes-eos-imaging-team-048ce238) — Source: Alphatec Holdings, Inc.